Biocodex
Overview
Biocodex is an independent multinational pharmaceutical company that operates as a corporate venture investor, focusing on innovative therapeutics involving probiotics or microbial strains, microbiota care, women's health, and orphan diseases.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Next-Microbiome | Oct 2025 | Series A Extension | Lead |
| Kinnov Therapeutics | Apr 2020 | Corporate Funding | Co-investor |
| Exeliom Biosciences | Oct 2025 | Series A Extension | Lead |
| MRM Health | Sep 2025 | Series B | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Biocodex based?
Biocodex is headquartered in Gentilly, France.
When was Biocodex founded?
Biocodex was founded in 1953.
How many portfolio companies does Biocodex have?
Biocodex has 4 portfolio companies in Caplight's dataset.
What are some companies in Biocodex's portfolio?
Portfolio companies visible on Caplight include Next-Microbiome, Kinnov Therapeutics, Exeliom Biosciences, MRM Health.
What was Biocodex's most recent investment shown here?
Biocodex's most recent investment in this portfolio sample was in Next-Microbiome in 2025.
What sectors does Biocodex focus on?
Biocodex focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Biocodex focus on?
Biocodex typically invests at the Early stage.